Skip to main content
Premium Trial:

Request an Annual Quote

OncoDNA, Eli Lilly Partner on Thyroid Cancer Biomarker Testing

NEW YORK — OncoDNA and Eli Lilly Italia, the Italian arm of Eli Lilly, said last week that they have been collaborating to provide biomarker testing for thyroid cancer in Italy.

According to the companies, they offer next-generation sequencing-based molecular testing on thyroid cancer biopsies to help clinicians identify gene alterations in tumors and link patients with targeted therapies.

"OncoDNA is extremely proud to have been selected by Lilly to broaden access to biomarker testing and deliver the promise of precision medicine for cancer patients in Italy," OncoDNA CEO Bernard Courtieu said in a statement. "We play a centralized role in the partnership … delivering tissue sample logistics, thyroid NGS testing services, [and] patient-specific treatment recommendations through our proprietary database on the secured OncoKDM platform."

Financial and other terms of the alliance were not disclosed.

Earlier this year, Belgium-based OncoDNA inked a deal with Synlab to provide cancer therapy selection in Germany.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.